Global Letrozole (CAS 112809-51-5) Market 2016 - Novartis, Shilpa Ltd, Natco, Sunpharma, TEVA, Synthon, Zhejiang Hisun, Xieli Pharma, Venture Pharma
Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
View full press release